Circulating microparticles in cardiovascular disease: going on stage!

References

• Bammert, T.D., Ashoket al., 2017. Influence of sex on the number of circulating endothelial microparticles and microRNA expression in middle-aged adults. Experimental physiology, 102(8), 894–900.
   PubMed Web of Science ®Google Scholar
• Benjamin, E. J., et al., 2017. Heart disease and stroke statistics – 2017 update: a report from the American Heart Association. Circulation, 135, e146–e603.
   PubMed Web of Science ®Google Scholar
• Bernal-Mizrachi, L., et al., 2004. Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. International journal of cardiology, 97(3), 439–446.
   PubMed Web of Science ®Google Scholar
• Bernal-Mizrachi, L., et al., 2003. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. American heart journal, 145(6), 962–970.
   PubMed Web of Science ®Google Scholar
• Braunwald, E., 2008. Biomarkers in heart failure. The new England journal of medicine, 358(20), 2148–2159.
   PubMed Web of Science ®Google Scholar
• Bulut, D., Tüns, H., and Mügge, A., 2009. CD31+/Annexin V + microparticles in healthy offsprings of patients with coronary artery disease. European journal of clinical investigation, 39(1), 17–22.
   PubMed Web of Science ®Google Scholar
• Burnier, L., et al., 2009. Cell-derived microparticles in haemostasis and vascular medicine. Thrombosis and haemostasis, 101(03), 439–451.
   PubMedGoogle Scholar
• Cardiovascular Diseases. 2018. (Fact sheet, update May 2017) from World Health Organization [Online]. [Accessed 8 March]
   Google Scholar
• Ceolotto, G., et al., 2017. miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways. Cardiovascular research, 113(13), 1627–1638.
   PubMed Web of Science ®Google Scholar
• Chargaff, E., and West, R., 1946. The biological significance of the thromboplastic protein of blood. The journal of biological chemistry, 166, 189–197.
   PubMed Web of Science ®Google Scholar
• Chironi, G., et al., 2006. Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arteriosclerosis, thrombosis, and vascular biology, 26(12), 2775–2780.
   PubMed Web of Science ®Google Scholar
• Chironi, G.N., et al., 2010. Circulating microparticles may influence early carotid artery remodeling. Journal of hypertension, 28(4), 789–796.
   PubMed Web of Science ®Google Scholar
• Chistiakov, D.A., Orekhov, A.N., and Bobryshev, Y.V., 2015. Extracellular vesicles and atherosclerotic disease. Cellular and molecular life sciences, 72, 2697–2708.
   PubMed Web of Science ®Google Scholar
• Chiva-Blanch, G., et al., 2017. Monocyte-derived circulating microparticles (CD14(+), CD14(+)/CD11b(+) and CD14(+)/CD142(+)) are related to long-term prognosis for cardiovascular mortality in STEMI patients. International journal of cardiology, 227, 876–881.
   PubMed Web of Science ®Google Scholar
• Christersson, C., Thulin, A., and Siegbahn, A., 2017. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events. Thrombosis and haemostasis, 117, 1571–1581.
   PubMed Web of Science ®Google Scholar
• Combes, V., et al., 1999. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. Journal of clinical investigation, 104(1), 93–102.
   PubMed Web of Science ®Google Scholar
• D'Agostino, R.B., Sr., et al., 2008. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation, 117, 743–753.
   PubMed Web of Science ®Google Scholar
• Diehl, P., et al., 2012. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovascular research, 93(4), 633–644.
   PubMed Web of Science ®Google Scholar
• Dorresteijn, J.A., et al., 2013. Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score. Heart, 99(12), 866–872.
   PubMed Web of Science ®Google Scholar
• Gustafson, C.M., et al., 2015. Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans. Biology of sex differences, 6, 10.
   PubMed Web of Science ®Google Scholar
• Hargett, L.A., and Bauer, N.N., 2013. On the origin of microparticles: from "platelet dust" to mediators of intercellular communication. Pulmonary circulation, 3(2), 329–340.
   PubMed Web of Science ®Google Scholar
• Hendel, R.C., Jabbar, A.Y., and Mahata, I., 2017. Initial diagnostic evaluation of stable coronary artery disease: the need for a patient-centered strategy. Journal of the American heart association, 6, e006863.
   PubMed Web of Science ®Google Scholar
• Hobbs, F.D., 2004. Cardiovascular disease: different strategies for primary and secondary prevention?. Heart (British cardiac society), 90(10), 1217–1223.
   PubMed Web of Science ®Google Scholar
• Horstman, L.L., et al., 2004. Endothelial microparticles as markers of endothelial dysfunction. Frontiers in bioscience, 9(1–3), 1118–1135.
   PubMedGoogle Scholar
• Jansen, F., et al., 2014. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. Journal of the American heart association, 3, e001249.
   PubMed Web of Science ®Google Scholar
• Jimenez, J.J., et al., 2003. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thrombosis research, 109(4), 175–180.
   PubMed Web of Science ®Google Scholar
• Laffont, B., and Rayner, K.J., 2017. MicroRNAs in the pathobiology and therapy of atherosclerosis. The Canadian journal of cardiology, 33 (3), 313–324.
   PubMed Web of Science ®Google Scholar
• Mallat, Z., et al., 2000. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation, 101(8), 841–843.
   PubMed Web of Science ®Google Scholar
• Marquardt, L., et al., 2010. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke; a journal of cerebral circulation, 41, e11–e17.
   PubMed Web of Science ®Google Scholar
• Miller, V.M., et al., 2016. Specific cell-derived microvesicles: linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women. Atherosclerosis, 246, 21–28.
   PubMed Web of Science ®Google Scholar
• Min, P.K., et al., 2013. Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction. Atherosclerosis, 227(2), 323–328.
   PubMed Web of Science ®Google Scholar
• Montoro-Garcia, S., et al., 2013. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. Atherosclerosis, 227, 313–322.
   PubMed Web of Science ®Google Scholar
• Nozaki, T., et al., 2010. Prognostic value of endothelial microparticles in patients with heart failure. European journal of heart failure, 12(11), 1223–1228.
   PubMed Web of Science ®Google Scholar
• Sarlon-Bartoli, G., et al., 2013. Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis. Journal of the American college of cardiology, 62(16), 1436–1441.
   PubMed Web of Science ®Google Scholar
• Sedgwick, A.E., and D'Souza-Schorey, C., 2018. The biology of extracellular microvesicles. Traffic (copenhagen, Denmark), 19(5), 319–327.
   PubMed Web of Science ®Google Scholar
• Suades, R., et al., 2016. Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time. International journal of cardiology, 202, 378–387.
   PubMed Web of Science ®Google Scholar
• van der Pol, E., et al., 2016. Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles. Journal of thrombosis and haemostasis, 14(1), 48–56.
   PubMed Web of Science ®Google Scholar
• Wekesa, A.L., et al., 2014. Predicting carotid artery disease and plaque instability from cell-derived microparticles. European journal of vascular and endovascular surgery: the official journal of the European society for vascular surgery, 48(5), 489–495.
   PubMed Web of Science ®Google Scholar
• Werner, N., et al., 2006. Circulating CD31+/annexin V + apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arteriosclerosis, thrombosis, and vascular biology, 26(1), 112–116.
   PubMed Web of Science ®Google Scholar
• Wolf, P., 1967. The nature and significance of platelet products in human plasma. British journal of haematology, 13(3), 269–288.
   PubMed Web of Science ®Google Scholar
• Yong, P.J., Koh, C.H., and Shim, W.S., 2013. Endothelial microparticles: missing link in endothelial dysfunction?. European journal of preventive cardiology, 20(3), 496–512.
   PubMed Web of Science ®Google Scholar
• Zhang, H.G., et al., 2016. Isolation, identification, and characterization of novel nanovesicles. Oncotarget, 7, 41346–41362.
   PubMedGoogle Scholar